Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression

Published:2018-10-01 Issue:4 Volume:21 Page:517-526
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Barajas Ramon F¹²,Hamilton Bronwyn E²,Schwartz Daniel³¹,McConnell Heather L³,Pettersson David R²,Horvath Andrea¹,Szidonya Laszlo³,Varallyay Csanad G³²,Firkins Jenny³,Jaboin Jerry J⁴,Kubicky Charlotte D⁴,Raslan Ahmed M⁵,Dogan Aclan⁵,Cetas Justin S⁵,Ciporen Jeremy⁵,Han Seunggu J⁵,Ambady Prakash³,Muldoon Leslie L³,Woltjer Randy⁶,Rooney William D¹,Neuwelt Edward A⁷⁵³

Affiliation:

1. Advanced Imaging Research Center, Portland, Oregon

2. Department of Radiology, Portland, Oregon

3. Department of Neurology, Portland, Oregon

4. Radiation Medicine, Portland, Oregon

5. Neurological Surgery, Portland, Oregon

6. Department of Pathology, Oregon Health and Science University, Portland, Oregon

7. Portland Veterans Affairs Medical Center, Portland, Oregon

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/21/4/517/28085696/noy160.pdf

Reference50 articles.

1. Standards of care and novel approaches in the management of glioblastoma multiforme;Hottinger;Chin J Cancer,2014

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

3. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

4. Long-term survival in glioblastoma possible. Updated results of the EORTC/NCIC phase III randomized trial on radiotherapy (RT) and concomitant and adjuvant temozolomide (TMZ) versus RT alone;Mirimanoff;Int J Radiat Oncol Biol Phys,2007

5. MGMT gene silencing and benefit from temozolomide in glioblastoma;Hegi;N Engl J Med,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the application of neuroinflammatory molecular imaging in brain malignancies;Frontiers in Immunology;2023-07-18

2. Multiparametric magnetic resonance imaging discerns glioblastoma immune microenvironmental heterogeneity;The Neuroradiology Journal;2023-06-12

3. Comparative in vitro and in vivo Evaluation of Different Iron Oxide-Based Contrast Agents to Promote Clinical Translation in Compliance with Patient Safety;International Journal of Nanomedicine;2023-04

4. An Updated Review on the Role of Nanoformulated Phytochemicals in Colorectal Cancer;Medicina;2023-03-30

5. Polymeric Metal Contrast Agents for T₁-Weighted Magnetic Resonance Imaging of the Brain;ACS Biomaterials Science & Engineering;2023-02-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3